The Global Therapy Partnering Terms and Agreements since
2010 report provides understanding and access to partnering deals and
agreements entered into by the world’s leading healthcare companies.
- Trends in partnering deals
- Top deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type
The report provides understanding and access to the
partnering deals and agreements entered into by the world’s leading healthcare
companies.
The report provides an analysis of partnering deals. The
majority of deals are discovery or development stage whereby the licensee
obtains a right or an option right to license the licensors technology. These
deals tend to be multicomponent, starting with collaborative R&D, and
commercialization of outcomes.
Understanding the flexibility of a prospective partner’s
negotiated deals terms provides critical insight into the negotiation process
in terms of what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments clauses,
the devil is in the detail in terms of how payments are triggered – contract
documents provide this insight where press releases do not.
This data driven report contains multiple links to online
copies of actual bladder cancer deals and contract documents as submitted to
the Securities Exchange Commission by companies and their partners, where
available. Contract documents provide the answers to numerous questions about a
prospective partner’s flexibility on a wide range of important issues, many of
which will have a significant impact on each party’s ability to derive value
from the deal.
The initial chapters of this report provide an orientation
of partnering trends.
Chapter 1 provides an overview of the trends in partnering since
2010, including a summary of deals by industry sector, stage of development,
deal type, and technology type.
Chapter 2 provides a review of the top 10 most active
companies in the therapy area, including a comprehensive listing of the deals
announced by each company.
Chapter 3 provides a comprehensive directory of partnering
deals signed and announced since 2010. The chapter is organized by company A-Z,
stage of development at signing, deal type (collaborative R&D,
co-promotion, licensing etc), and technology type. Each deal title links via
Weblink to an online version of the deal record, and where available the
contract document, providing easy access to each contract document on demand.
Chapter 4 provides a listing of partnering deals where a
contract document is available alongside the deal record.
Chapters 5 and 6 provide a summary of M&A deals since
2010 where the acquired company is active in the therapy area of interest.
Chapters 7 and 8 provide a summary of financings since 2010
where the financed company is active in the therapy area of interest.
In conclusion, this report provides everything a prospective
dealmaker needs to know about partnering in the research, development and
commercialization of technologies and products in the therapy area.
Benefits
Global Therapy Partnering Terms and Agreements since 2010
report provides the reader with the following key benefits:
- In-depth understanding of deal trends since 2010
- Access to headline, upfront, milestone and royalty data
- Comprehensive access to multiple deals entered into by the world’s biopharma companies since 2010
- Insight into key deal terms included in contracts, where disclosed
- Understand the key deal terms companies have agreed in deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Spanning over 200 pages “Global Surgery
Partnering 2010 to 2016” report covers Executive Summary, Therapypartnering trends
in numbers, Most active dealmakers, Partnering deals directory, Partnering
deals with a contract document, M&A in numbers, M&A deals directory,
Financing in numbers, Financing deals directory.
For
more information Visit at: http://mrr.cm/333
Related Reports;
Global Transplantation Partnering 2010 to 2016 - Visit at - http://mrr.cm/33U
Global AIDS Partnering 2010 to 2016 - Visit at - http://mrr.cm/33w
Global Allergy Partnering 2010 to 2016 - Visit at - http://mrr.cm/33i
Global Hepatitis Partnering 2010 to 2016 - Visit at - http://mrr.cm/335
No comments:
Post a Comment
Note: only a member of this blog may post a comment.